Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
60–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Gradual and progressive change in memory function reported by participants or informants for ≥ 6 months.
MMSE score of 20 to 28 (inclusive) at baseline or an acceptable historical flortaucipir PET scan within 6 months prior to baseline that meets the central read criteria.
Meet 18F flortaucipir PET scan eligibility criteria.
Meet 18F florbetapir PET scan (central read) eligibility criteria.
You may not be if
Have a history of long QT syndrome.
Have received treatment with a stable dose of an acetylcholinesterase inhibitor (AChEI) and/or memantine for less than 2 months before randomization.
